Grantham, Mayo, Van Otterloo & Co (GMO)’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-980,800
| Closed | -$3.09M | – | 919 |
|
|
2020
Q3 | $3.09M | Sell |
980,800
-127,100
| -11% | -$400K | 0.02% | 326 |
|
|
2020
Q2 | $3.22M | Buy |
1,107,900
+113,600
| +11% | +$331K | 0.02% | 323 |
|
|
2020
Q1 | $2.8M | Sell |
994,300
-137,700
| -12% | -$388K | 0.02% | 335 |
|
|
2019
Q4 | $3.67M | Sell |
1,132,000
-197,600
| -15% | -$641K | 0.02% | 321 |
|
|
2019
Q3 | $2.87M | Sell |
1,329,600
-349,300
| -21% | -$755K | 0.02% | 369 |
|
|
2019
Q2 | $5.27M | Sell |
1,678,900
-4,900
| -0.3% | -$15.4K | 0.04% | 280 |
|
|
2019
Q1 | $6.26M | Buy |
+1,683,800
| New | +$6.26M | 0.05% | 231 |
|
|
2017
Q2 | – | Sell |
-63,997
| Closed | -$145K | – | 647 |
|
|
2017
Q1 | $145K | Sell |
63,997
-1,006,512
| -94% | -$2.28M | ﹤0.01% | 531 |
|
|
2016
Q4 | $2.27M | Sell |
1,070,509
-1,224,725
| -53% | -$2.6M | 0.01% | 278 |
|
|
2016
Q3 | $7.69M | Sell |
2,295,234
-557,868
| -20% | -$1.87M | 0.04% | 209 |
|
|
2016
Q2 | $8.96M | Buy |
2,853,102
+395,987
| +16% | +$1.24M | 0.04% | 234 |
|
|
2016
Q1 | $8.18M | Buy |
2,457,115
+2,260,415
| +1,149% | +$7.53M | 0.03% | 253 |
|
|
2015
Q4 | $696K | Sell |
196,700
-2,300
| -1% | -$8.14K | ﹤0.01% | 418 |
|
|
2015
Q3 | $1M | Buy |
+199,000
| New | +$1M | ﹤0.01% | 403 |
|
|
2014
Q1 | – | Sell |
-42,543
| Closed | -$359K | – | 725 |
|
|
2013
Q4 | $359K | Sell |
42,543
-5,064
| -11% | -$42.7K | ﹤0.01% | 603 |
|
|
2013
Q3 | $379K | Sell |
47,607
-9,326
| -16% | -$74.2K | ﹤0.01% | 594 |
|
|
2013
Q2 | $440K | Buy |
+56,933
| New | +$440K | ﹤0.01% | 551 |
|